S. Gutierrez et al., Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer - A study using the micronucleus test, EUR J NUCL, 26(12), 1999, pp. 1589-1596
Citations number
46
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
To detect the incidence and persistence of potential chromosome damage indu
ced by iodine-131 therapy, we applied the cytokinesis-block micronucleus as
say to peripheral blood lymphocytes from hyperthyroidism and thyroid cancer
patients treated with I-131. Two groups of patients were evaluated in a lo
ngitudinal study; one group was composed of 47 hyperthyroid patients and th
e other of 39 thyroid cancer patients. In the hyperthyroidism group, the mi
cronuclei frequency was determined before I-131 therapy and 1 week, 1 month
and 3 months after it. Furthermore, an additional sample was taken from a
subgroup of 17 hyperthyroidism patients 6 months after treatment. In the th
yroid cancer group, the analysis was also conducted over time, and four sam
ples were studied: before treatment and 1 week, 6 months and 1 year later.
Simultaneously, a cross-sectional study was performed with 70 control subje
cts and 54 thyroid cancer patients who had received the last therapeutic do
se 1-6 years before the present study. In the hyperthyroidism group a signi
ficant increase in the micronuclei average was found over time. In the samp
le obtained 6 months after therapy, the micronuclei mean frequency was prac
tically the same as in the sample taken 3 months before. In the thyroid can
cer group a twofold increase in the frequency of micronuclei was seen 1 wee
k after therapy. Although this value decreased across time, the micronuclei
frequency obtained 1 year after I-131 therapy remained higher than the val
ue found before it. Concerning the data from the cross-sectional study, a s
ignificant increase in the frequency of micronuclei was detected in the sub
group of thyroid cancer patients treated between 1 and 3 years before the c
urrent study. These results indicate that exposure to I-131 therapy induces
chromosome damage in peripheral lymphocytes and that the cytokinesis-block
micronucleus assay is sensitive enough to detect the generic damage by exp
osure to sufficiently high levels of radiation from internal radioactive so
urces.